| 摘要: |
| 急性肺损伤(acute lung injury, ALI)是以肺部炎症和组织损伤为病理特征的临床危重疾病,主要的病因包括严重肺感染等直接肺损伤因素和脓毒症、重症胰腺炎等间接肺损伤因素,ALI可快速发展为急性呼吸窘迫综合征,且伴随高发病率和高死亡率。纳米酶是一种具有酶模拟性质的基于纳米材料的催化剂,较普通的生物酶有较高的催化活性,但因其较小的尺寸,可能会引起系列的生物安全性。本文就纳米酶对急性肺损伤的保护作用及其毒性研究进行综述。 |
| 关键词: 纳米酶 急性肺损伤 保护作用 毒性 |
| DOI:10.13506/j.cnki.jpr.2025.10.013 |
| 基金项目:广西自然科学基金重点项目(No.2020GXNSFDA238028) |
|
出版日期:2025-10-25
|
|
| Research progress on the protective effeet of drug containing nanoenzymes onacute lung injury and nanoenzyme toxicity |
| YANG Ke,YAN Chaohui,ZENG Chunhui |
| (Guangxi University of Chinese Medicine, Nanning 530200, China) |
| Abstract: |
| Acute lung injury (ALI) is a clinical critical disease characterized by lung inflammation and tissue injury. The main causes include direct lung injury factors such as severe lung infection, as well as indirect lung injury factors such as sepsis. ALI can rapidly develop into acute respiratory distress syndrome with high morbidity and mortality. Nanomaterials are catalysts based on nanomaterials with enzymatic simulation properties, which have higher catalytic activity than common biological enzymes. However, due to their smaller size, they may cause a series of biological safety issues. This article reviewed the protective effect and toxicity research of nanomaterials on acute lung injury. |
| Key words: Nanomaterials Acute lung injury Protective effect Toxicity |